U.S. flag

An official website of the United States government

NM_000194.3(HPRT1):c.143G>A (p.Arg48His) AND Partial hypoxanthine-guanine phosphoribosyltransferase deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 1, 2011
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001255647.2

Allele description [Variation Report for NM_000194.3(HPRT1):c.143G>A (p.Arg48His)]

NM_000194.3(HPRT1):c.143G>A (p.Arg48His)

Gene:
HPRT1:hypoxanthine phosphoribosyltransferase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq26.2
Genomic location:
Preferred name:
NM_000194.3(HPRT1):c.143G>A (p.Arg48His)
HGVS:
  • NC_000023.11:g.134475189G>A
  • NG_012329.2:g.20045G>A
  • NM_000194.3:c.143G>AMANE SELECT
  • NP_000185.1:p.Arg48His
  • NC_000023.10:g.133609219G>A
  • NG_012329.1:g.20045G>A
  • NM_000194.2:c.143G>A
  • P00492:p.Arg48His
Protein change:
R48H; ARG48HIS
Links:
UniProtKB: P00492#VAR_006761; OMIM: 308000.0060; dbSNP: rs387906725
NCBI 1000 Genomes Browser:
rs387906725
Molecular consequence:
  • NM_000194.3:c.143G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Partial hypoxanthine-guanine phosphoribosyltransferase deficiency
Synonyms:
GOUT, HPRT-RELATED; HPRT DEFICIENCY, PARTIAL; HPRT1 DEFICIENCY, PARTIAL; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010299; MedGen: C0268117; Orphanet: 79233; OMIM: 300323

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001432208OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 2011)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants.

Sampat R, Fu R, Larovere LE, Torres RJ, Ceballos-Picot I, Fischbach M, de Kremer R, Schretlen DJ, Puig JG, Jinnah HA.

Hum Genet. 2011 Jan;129(1):71-8. doi: 10.1007/s00439-010-0901-9. Epub 2010 Oct 28.

PubMed [citation]
PMID:
20981450
PMCID:
PMC3034646

Details of each submission

From OMIM, SCV001432208.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 9 patients from 7 unrelated families with the neurologic variant of Lesch-Nyhan syndrome (see 300322), Sampat et al. (2011) identified a 143G-A transition in the HPRT gene, resulting in an arg48-to-his (R48H) substitution in an alpha-2 helix at the interface between dimerization of the protein. An additional patient with hyperuricemia and impulsive/oppositional behavior, whom the authors classified as having HPRT-related hyperuricemia (HRH; 300323), also carried the mutation. The mutation likely arose independently multiple times, because it occurred at a CpG motif. There was almost no detectable HPRT enzyme activity in patient erythrocytes, but there was some residual activity in patient fibroblasts. Kinetic studies in E. coli showed that the mutant enzyme had normal affinity for hypoxanthine and guanine, but V(max) was decreased by 33% and 37% for those substrates, respectively, compared to wildtype. However, additional studies showed that the mutant protein had poor thermal stability, with only 16% residual activity at 37 degrees C and undetectable activity at 55 degrees C, which may have explained the variable phenotypic consequences in mutation carriers.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 26, 2024